Your data on MRCVSonline
The nature of the services provided by Vision Media means that we might obtain certain information about you.
Please read our Data Protection and Privacy Policy for details.

In addition, (with your consent) some parts of our website may store a 'cookie' in your browser for the purposes of
functionality or performance monitoring.
Click here to manage your settings.
If you would like to forward this story on to a friend, simply fill in the form below and click send.

Your friend's email:
Your email:
Your name:
 
 
Send Cancel

Save the Children conducting Ebola case review
The review will look at safety protocols, training, working practices and how protective equipment is used.

Review to look at how Pauline Cafferkey contracted the disease

Save the Children has announced that is has been conducting a case review since UK Ebola nurse Pauline Cafferkey was confirmed with the disease on 29 December 2014.

The Serious Event Review is looking at how the nurse could have contracted Ebola by reviewing safety protocols, training, working practices, and how protective equipment is used.

The review findings will be deliberated by a panel which includes independent health experts, who will support Save the Children and make recommendations for any actions if necessary.  

In a statement, Save the Children said: "As with other Ebola infections in health facilities, it may never be possible to be 100% sure how the patient was infected. The work of these brave health workers is never risk-free, but we are committed to doing everything possible to learn what happened and, if necessary, to make changes to our protocols and practice. Staff safety is our number one priority and our thoughts are with Pauline and her family at this very difficult time.”

Save the Children added that early findings of the review will be made available "as soon as possible."

Image (C) European Commission DG ECHO 

Become a member or log in to add this story to your CPD history

Annual submission deadline small pet animal exemptions

News Story 1
 Companies marketing medicines for small pets exempt from authorisation must submit their annual return to the Veterinary Medicines Directorate (VMD) by 30 November 2026.

Submitting this annual return ensures continued compliance with regulatory requirements for products marketed without a full Marketing Authorisation. The exemption specifically applies to products intended for animals, cage birds, terrarium animals, small rodents, ferrets and rabbits.

For further details and submission guidelines, visit the gov.uk website.  

Click here for more...
News Shorts
BVA urges 'continued vigilance' over bluetongue

The British Veterinary Association (BVA) has urged vigilance following a concerning rise in Bluetongue (BTV) cases in sheep and cattle.

In a recent statement, the BVA noted that members are reporting more severe clinical signs and higher mortality rates than in previous years.

'We know that farm vets are working hard to support farmers and animals affected by this outbreak, during what is an extremely difficult time for all involved,' they stated. 'Continued vigilance to identify disease early is vital and vaccination remains the best way of protecting animals from this disease.'